As of October 20, 2026, Kenya has confirmed nine cases of Bundibugyo virus disease. One person has died. 135 contacts are under quarantine. Because the Bundibugyo strain has no approved vaccine and no licensed therapeutic, the entire response relies on one thing: the health system’s ability to isolate, treat, and contain the virus without infecting the very healthcare workers trying to save lives. We have moved past the question of whether Kenya can detect an imported case at the airport. The question now is: Can Kenya safely and scalably treat the cases it already has? I recently conducted a comprehensive assessment of Kenya’s clinical care pillar against WHO and CDC benchmarks. I looked at six components: treatment facilities, clinical workforce, WASH infrastructure, medical supplies, referral pathways, and the continuity of essential health services. The conclusion is unavoidable: Kenya cannot deliver safe and scalable care for BVD at this moment. Here is the evidenc...
“Onjalazbroz is the East African analytical voice on global affairs, public-health systems, and the post-colonial condition — written from Kisumu, read globally, and unafraid to name empire when it sees it."